India, Jan. 30 -- Know Labs, Inc. (KNWN), a Washington-based medical device company Wednesday announced that it is taking initiatives to regain compliance and appeal the NYSE's decision to delist its common stock to the Listings Qualifications Panel.
During this process, the company's stock will be suspended from trading on NYSE American. NYSE Regulation has initiated delisting proceedings after determining that the Company no longer meets the listing criteria due to its bid price falling below $0.10, as outlined in Section 1003(f)(v) of the NYSE American Company Guide.
In the meantime, starting January 29, FINRA's Department of Market Operations has assigned the symbol "KNWN" for the quotation and trading of the Company's stock on the ov...